The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)-Reference-Cited by-同舟云学术

The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)

Published:2019 Issue: Volume:19 Page:100123
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Najim Omar,Huizing Manon,Papadimitriou Konstantinos,Trinh Xuan Bich,Pauwels Patrick,Goethals Sofie,Zwaenepoel Karen,Peterson Kevin,Weyler Joost,Altintas Sevilay,van Dam Peter,Tjalma Wiebren

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. The application of estrogen receptor-1 mutations’ detection through circulating tumor DNA in breast cancer;Liu;Cancer Transl. Med.,2017

2. Estrogen receptors as therapeutic targets in breast cancer;Ariazi;Curr.Top. Med. Chem.,2006

3. Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole;Gyanchandani;Oncotarget,2017

4. ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients;Chu;Clin. Cancer. Res.,2016

5. The evolving role of the estrogen receptor mutations in endocrine therapy-resistant breast cancer;Jeselsohn;Curr. Oncol. Rep.,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis;Frontiers in Oncology;2023-08-22

2. Computational pathology to improve biomarker testing in breast cancer: how close are we?;European Journal of Cancer Prevention;2023-04-10

3. CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients;Cancers;2023-02-18

4. Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer;Scientific Reports;2023-01-23

5. ESR1 Mutations as a Predictor of Progression and Metastasis of Hormone-Dependent Breast Cancer;Ukraïnsʹkij žurnal medicini, bìologìï ta sportu;2022-12-28